Akutkomplikationen bei Typ-1-Diabetes im Kindes- und Jugendalter

ZUSAMMENFASSUNG

Die Diagnose eines Typ 1 Diabetes mellitus stellt – trotz großer technischer und pharmakologischer Errungenschaften in der letzten Dekade – weiterhin eine sehr große Belastung für Patient, Angehörige und familiäres Umfeld dar. Neben der Diskussion hinsichtlich der optimalen Therapieführung, und Verringerung bzw. Vermeidung von Folgeschäden der Erkrankung, sind potenziell auftretende Akutkomplikationen, sowohl hypo- als auch hyperglykämischer Art, eine alltägliche Herausforderung für die Patienten. Trotz der sukzessiven Abnahme der Anzahl an diabetischen Ketoazidosen bei bekanntem Diabetes und schweren Hypoglykämien in den letzten Jahren, stellt – insbesondere im Kleinkindalter – die diabetische Ketoazidose im Rahmen der Diabetesmanifestation weiterhin ein ungelöstes Problem dar.

• Literatur

• 1 Weng J, Zhou Z, Guo L. et al Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ 2018; 360: j5295 doi:10.1136/bmj.j5295
• 2 Abraham MB, Jones TW, Naranjo D. et al Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 2018 Suppl 27 178-192 doi:10.1111/pedi.12698
• 3 Diabetes Research in Children Network Tsalikian E, Tamorlane W. et al Blunted conterregulatory hormone responses to hypoglycemia in young children and adolescents with well controlled type 1 diabetes. Diabetes Care 2009; 32: 1954-1959 doi:10.2337/dc08-2298
• 4 Kaufman FR, Austin J, Neinstein A. et al Nocturnal hypoglycemia detected with the continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. J Pediatr 2002; 141: 625-630 doi:10.1067/mpd.2002.129175
• 5 Tauschmann M, Hermann JM, Freiberg C. et al Reduction in diabetic ketoacidosis and severe hypoglycemia in pediatric type 1 diabetes during the first year of continuous glucose monitoring: a multicenter analysis of 3,553 subjects from the DPV Registry. Diabetes Care 2020 pii: dc191358. doi:10.2337/dc19-1358
• 6 Haynes A, Hermann JM Clapin. et al Decreasing trens in mean HbA_1c are not associated with increasing rates of severe hypoglycemia in children: A longitudinal Analysis of two contemporary population-based pediatric Type 1 diabetes registries from Australia and Germany/ Austira between, 1995 and 2016. Diabetes Care 2019; 42: 1630-1636 doi:10.2337/dc18-2448
• 7 Adolfsson P, Riddel MC, Taplin CE. et al ISPAD Clinical Practice consensus guidelines, 2018: Exercise in children and adolescents with diabetes. Pediatr Diabetes 2018; 19: 205-226 doi:10.1111/pedi.12755
• 8 Cengiz E, Xing D, Wong JC. et al Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes 2013; 14: 447-454 doi:10.1111/pedi.12030
• 9 Yale JF, Dulude H, Egeth M. et al Faster use and fewer failures with needle-free nasal glucagon versus injectable glucagon in severe hypoglycemia rescue: a simulation study. Diabetes Technol Ther 2017; 19: 423-432 doi:10.1089/dia.2016.0460
• 10 Manuwald U, Schoffer O, Hegewald J. et al Ketoacidosis at onset of type 1 diabetes in children up to 14 years of age and the changes over a period of 18 years in Saxony, Eastern-Germany: A population based register study. PLoS One 2019; 14: e0218807 doi:10.1371/journal.pone.0218807
• 11 Sottosanti M, Morrison GC, Singh RN. et al Dehydration in children with diabetic ketoacidosis: a prospective study. Arch Dis Child 2012; 97: 96-100 doi:10.1136/archdischild-2011-300173
• 12 Von Oettingen JE, Rhodes ET, Wolfsdorf JI. Resolution of ketoacidosis in children with new onset diabetes: Evaluation of various definitions. Diabetes Res Clin Pract 2018; 135: 76-84 doi:10.1016/j.diabres.2017.09.011
• 13 Decourcey DD, Steil GM, Wypij D. et al Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality*. Pediatr Crit Care Med 2013; 14: 694-700 doi:10.1097/PCC.0b013e3182975cab
• 14 Cameron FJ, Scratch SE, Nadebaum C. et al Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children. Diabetes Care 2014; 37: 1554-1562 doi:10.2337/dc13-1904
• 15 Aye T, Mazaika PK, Mauras N. et al Impact of early diabetic ketoacidosis on the developing brain. Diabetes Care 2019; 42: 443-449 doi:10.2337/dc18-1405
• 16 Duca LM, Wang B, Rewers M. et al Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control. Diabetes Care 2017; 40: 1249-1255 doi:10.2337/dc17-0558
• 17 Shalitin S, Fisher Yackbovitch-Gavan M. et al Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control. Pediatr Diabetes 2018; 19: 320-328 doi:10.1111/pedi.12546
• 18 Jones R, Redler K, Witherick J. et al Posterior reversible encephalopathy syndrome complicating diabetic ketoacidosis; an important treatable complication. Pediatr Diabetes 2017; 18: 159-162 doi:10.1111/pedi.12362
• 19 Agrawal S, Baird GL, Quintos JB. et al Pediatric diabetic ketoacidosis with hyperosmolarity: Clinical cheracteristics and outcomes. Endocr Pract 2018; 24: 726-732 doi:10.4158/EP-2018-0120
• 20 Zeitler P, Haqq A, Rosenbloom A. et al Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment. J Pediatr 2011; 158: 9-14 14.e1-2 doi:10.1016/j.jpeds.2010.09.048
• 21 Wolfsdorf JI, Glaser N, Agus M. et al ISPAD Clinical Practice Guidelines, 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 2018; 19 (Suppl. 27) 155-177 doi:10.1111/pedi.12701
• 22 Rodbard D. Continuous glucose monitoring: A review of recent studies demonstrating improved glycemic outcomes. Diabetes Technol Ther 2017; 19: S25-237 doi:10.1089/dia.2017.0035
• 23 Berget C, Messer LH, Vigers T. et al Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670 G system. Pediatr Diabetes 2020; 21: 310-318 doi:10.1111/pedi.12962
• 24 Hernando ME, García-Sáez G, Gomez EJ. et al Automated indulin delivery: The artificial pancreas technical challenges. Am J Ther 2020; 27: e62-e70 doi:10.1097/MJT.0000000000001086
• 25 Holder M, Ehehalt S. Deutliche Reduktion der diabetischen Ketoazidose bei Manifestation – Ergebnisse der Stuttgarter Ketoazidose Präventionskampagne. Diabetologie und Stoffwechsel 2019; 14: S27-28 doi:10.1055/s-0039-1688185
• 26 Mortensen H, Hougaard P. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidøre Study Group on Childhood Diabetes. Diabetes Care 1997; 20: 714-720 doi: 10.2337/diacare.20.5.714
• 27 Danne T, Battelino T, Jarosz-Chonot P. et al A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Diabetologia 2008; 51: 1594-1601 doi:10.1007/s00125-008-1072-2